SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001683168-24-004755
Filing Date
2024-07-11
Accepted
2024-07-11 16:00:03
Documents
1
Period of Report
2024-06-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY sunshine_def14c.htm DEF 14C 70696
  Complete submission text file 0001683168-24-004755.txt   72013
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-41282 | Film No.: 241112035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)